Huntsman Ronald Kirk 4
4 · Vivos Therapeutics, Inc. · Filed Aug 18, 2021
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2021-08-17$3.00/sh+5,000$15,000→ 10,500 total
Holdings
- 1,740,000(indirect: See footnote)
Common Stock
- 333,334
Stock Option (Right to Buy)
Exercise: $1.65Exp: 2022-09-30→ Common Stock (333,334 underlying)
Footnotes (2)
- [F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
- [F2]The option provides for vesting in five equal annual installments beginning on January 15, 2017.